The effects of iclaprim on exotoxin production in methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
CONCLUSIONS: We conclude that, due to its ability to suppress toxin production, iclaprim should be effective against severe staphylococcal infections caused by toxin-producing MRSA and VISA strains, especially given its ability to concentrate at sites of infection such as skin and skin structures and the lung.
PMID: 30676310 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Bryant AE, Gomi S, Katahira E, Huang DB, Stevens DL Tags: J Med Microbiol Source Type: research
More News: Folic Acid | Genetics | Infectious Diseases | Microbiology | MRSA | Skin | Staphylococcus Aureus | Study | Superbugs | Toxic Shock Syndrome | Toxicology | Trimethoprim | Vitamin B9